Farmakologisk hypertensionsbehandling

Ole Lederballe Pedersen; Kent Lodberg Christensen; Lia E Bang; Hans Ibsen; Peter Schultz-Larsen

Farmakologisk hypertensionsbehandling

Ole Lederballe Pedersen
, Kent Lodberg Christensen
, Lia E Bang
, Hans Ibsen
, Peter Schultz-Larsen

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Drug therapy in uncomplicated hypertension can be initiated with either ACE-inhibitors, angiotensin II receptor antagonists, calcium channel blockers or thiazides. In younger patients, the first three classes are preferable. Beta-blockers are first-line drugs for hypertension in patients with cardiac comorbidity. Initial combination therapy is indicated in high-risk patients where blood pressure reduction of > 20/10 mmHg is desired. Resistant hypertension generally calls for an increment in diuretic dosage and/or addition of a potassium-sparing diuretic.
Udgivelsesdato: 2009-Jun-8

Bidragets oversatte titel	Pharmacological hypertension therapy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for læger
Vol/bind	171
Udgave nummer	24
Sider (fra-til)	2022-5
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 2009

Bibliografisk note

Keywords: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Thiazides

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{cc808e4064cb11df928f000ea68e967b,

title = "Farmakologisk hypertensionsbehandling",

abstract = "Drug therapy in uncomplicated hypertension can be initiated with either ACE-inhibitors, angiotensin II receptor antagonists, calcium channel blockers or thiazides. In younger patients, the first three classes are preferable. Beta-blockers are first-line drugs for hypertension in patients with cardiac comorbidity. Initial combination therapy is indicated in high-risk patients where blood pressure reduction of > 20/10 mmHg is desired. Resistant hypertension generally calls for an increment in diuretic dosage and/or addition of a potassium-sparing diuretic. Udgivelsesdato: 2009-Jun-8",

author = "Pedersen, \{Ole Lederballe\} and Christensen, \{Kent Lodberg\} and Bang, \{Lia E\} and Hans Ibsen and Peter Schultz-Larsen",

note = "Keywords: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Thiazides",

year = "2009",

language = "Dansk",

volume = "171",

pages = "2022--5",

journal = "Ugeskrift for l{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "24",

}

TY - JOUR

T1 - Farmakologisk hypertensionsbehandling

AU - Pedersen, Ole Lederballe

AU - Christensen, Kent Lodberg

AU - Bang, Lia E

AU - Ibsen, Hans

AU - Schultz-Larsen, Peter

N1 - Keywords: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Thiazides

PY - 2009

Y1 - 2009

N2 - Drug therapy in uncomplicated hypertension can be initiated with either ACE-inhibitors, angiotensin II receptor antagonists, calcium channel blockers or thiazides. In younger patients, the first three classes are preferable. Beta-blockers are first-line drugs for hypertension in patients with cardiac comorbidity. Initial combination therapy is indicated in high-risk patients where blood pressure reduction of > 20/10 mmHg is desired. Resistant hypertension generally calls for an increment in diuretic dosage and/or addition of a potassium-sparing diuretic. Udgivelsesdato: 2009-Jun-8

AB - Drug therapy in uncomplicated hypertension can be initiated with either ACE-inhibitors, angiotensin II receptor antagonists, calcium channel blockers or thiazides. In younger patients, the first three classes are preferable. Beta-blockers are first-line drugs for hypertension in patients with cardiac comorbidity. Initial combination therapy is indicated in high-risk patients where blood pressure reduction of > 20/10 mmHg is desired. Resistant hypertension generally calls for an increment in diuretic dosage and/or addition of a potassium-sparing diuretic. Udgivelsesdato: 2009-Jun-8

M3 - Tidsskriftartikel

C2 - 19523367

SN - 0041-5782

VL - 171

SP - 2022

EP - 2025

JO - Ugeskrift for læger

JF - Ugeskrift for læger

IS - 24

ER -